Myriad Genetics is a healthcare company focused on the development and marketing of novel molecular diagnostic products. We are committed to improve patient healthcare through the commercialization of predictive medicine, personalized medicine, and prognostic medicine products.

Our goal is to introduce new molecular diagnostic products that provide life-saving information, improve the quality of life, and save the healthcare system money.

Listen to the archived OnDose webcast

Recorded on June 18, 2009